This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

---

---

Moxifloxacin

AVELOX, AVELOX I.V., IZILOX, IZILOX I.V., VIGAMOX – Bayer Inc. (NOC Search)

Patents:

• 1340114: PHARMASCIENCE, APOTEX, NOVOPHARM, , TEVA, COBALT, MYLAN, PHARMACEUTICAL PARTNERS, AURO, ACTAVIS
• 1340553: TEVA
• 2086914: PHARMASCIENCE, NOVOPHARM, APOTEX, COBALT, TEVA, MYLAN, AURO
• 2107812: MYLAN, PHARMASCIENCE
• 2192418: AURO, ACTAVIS, TEVA, COBALT, PHARMACEUTICAL PARTNERS, MYLAN, APOTEX, NOVOPHARM, , PHARMASCIENCE
• 2342211: ACTAVIS, APOTEX, COBALT, TEVA
• 2378424: PHARMACEUTICAL PARTNERS,

Unknown/Other

• PM(NOC) – A-236-16 – T-1440-14 (2015 FC 388, 2016 FC 581, 2016 FC 970, 2015 FC 797) – T-1837-15

ACTAVIS

• Appeal – A-284-14 (2015 FCA 191) – A-286-14 (2015 FCA 192)

APOTEX

• PM(NOC) – T-1653-12 – T-2178-12 – T-2179-12

AURO

• PM(NOC) – T-1875-14

COBALT

• PM(NOC) – T-972-12 (2014 FC 462)

MYLAN

• PM(NOC) – T-11-13

NOVOPHARM

• PM(NOC) – T-1256-06

PHARMACEUTICAL PARTNERS

• PM(NOC) – A-312-15 (2016 FCA 13) – T-1092-14 – T-1260-14

PHARMASCIENCE

• PM(NOC) – T-1211-14

TEVA

• PM(NOC) – T-1414-13 – T-1415-13

---

Return to the Patented Medicine Litigation page.